Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MICC
1851
The Magnum Ice Cream Company N.V.
MICC
$11.6B
| $30M | 0.01% |
+1,723,346
| New | +$26.8M |
|
1852
Arrow Financial
AROW
$711M
| $29.7M | 0.01% |
725,492
-4,979
| -0.7% | -$185K |
|
1853
Mistras Group
MG
$633M
| $29.7M | 0.01% |
1,700,793
-2,888
| -0.2% | -$51.4K |
|
1854
InterContinental Hotels
IHG
$22.6B
| $29.7M | 0.01% |
171,354
+355
| +0.2% | +$54.3K |
|
1855
Compass Minerals
CMP
$1.01B
| $29.6M | 0.01% |
951,151
+37,468
| +4% | +$1.06M |
|
1856
Viridian Therapeutics
VRDN
$2.47B
| $29.6M | 0.01% |
1,611,521
+1,081,758
| +204% | +$17.4M |
|
1857
BioLife Solutions
BLFS
$1.79B
| $29.5M | 0.01% |
1,046,252
+10,495
| +1% | +$245K |
|
1858
Waterstone Financial
WSBF
$371M
| $29.4M | 0.01% |
1,417,945
+4,443
| +0.3% | +$82.8K |
|
1859
Alerus Financial
ALRS
$822M
| $29.3M | 0.01% |
943,445
+56,630
| +6% | +$1.56M |
|
1860
Sunstone Hotel Investors
SHO
$2.06B
| $29.3M | 0.01% |
2,561,666
-29,573
| -1% | -$310K |
|
1861
Donnelley Financial Solutions
DFIN
$1.2B
| $29.3M | 0.01% |
699,080
+12,749
| +2% | +$556K |
|
1862
Mayville Engineering Co
MEC
$450M
| $29.3M | 0.01% |
782,276
-143,940
| -16% | -$3.85M |
|
1863
AtriCure
ATRC
$2.98B
| $29.2M | 0.01% |
1,044,034
+46,275
| +5% | +$1.3M |
|
1864
John B. Sanfilippo & Son
JBSS
$805M
| $29.1M | 0.01% |
338,753
+25,951
| +8% | +$2.05M |
|
|
EFOR
1865
Everforth Inc
EFOR
$1.34B
| $29.1M | 0.01% |
1,626,085
-269,038
| -14% | -$6.57M |
|
|
NTST
1866
NETSTREIT Corp
NTST
$1.84B
| $29.1M | 0.01% |
1,374,833
+97,125
| +8% | +$1.97M |
|
1867
Wendy's
WEN
$1.36B
| $29M | 0.01% |
3,499,298
+22,562
| +0.6% | +$161K |
|
1868
Civista Bancshares
CIVB
$568M
| $28.9M | 0.01% |
1,025,247
+74,917
| +8% | +$1.9M |
|
1869
Central Garden & Pet Co
CENT
$2.55B
| $28.9M | 0.01% |
650,817
+941
| +0.1% | +$36.9K |
|
1870
Coastal Financial
CCB
$705M
| $28.9M | 0.01% |
372,280
+12,709
| +4% | +$955K |
|
1871
Fortrea Holdings
FTRE
$1.95B
| $28.7M | 0.01% |
1,650,100
+350,238
| +27% | +$4.73M |
|
|
FSUN
1872
FirstSun Capital Bancorp
FSUN
$1.74B
| $28.7M | 0.01% |
739,703
+341,341
| +86% | +$12.5M |
|
1873
Corsair Gaming
CRSR
$1.48B
| $28.6M | 0.01% |
2,960,712
+637,845
| +27% | +$4.94M |
|
1874
Compass
COMP
$8.08B
| $28.5M | 0.01% |
2,315,251
-13,069,000
| -85% | -$109M |
|
1875
Monte Rosa Therapeutics
GLUE
$1.08B
| $28.5M | 0.01% |
1,177,488
+136,116
| +13% | +$2.57M |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.